MET Stock Up 5.4% after 5-Day Win Streak
MetLife (MET) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 5.4% return. The company has gained about $2.9 Bil in value over the last 5 days, with its current market capitalization at about $55 Bil. The stock remains 1.7% above its value at the end of 2024. This compares with year-to-date returns of 10% for the S&P 500.
MET provides insurance, annuities, employee benefits, and asset management services across multiple regions, offering life, dental, disability, pet, vision, and accident health coverages. After this rally, is MET still a buy – or is it time to lock in gains? Deep dive with Buy or Sell MET.
Comparing MET Stock Returns With The S&P 500
The following table summarizes the return for MET stock vs. the S&P 500 index over different periods, including the current streak:
- How To Trade MetLife Stock Ahead Of Q2 Earnings?
- What To Expect From MetLife Stock In 2025?
- MetLife Stock Is Trailing S&P500 In YTD Returns, What To Expect?
- Dropping 5% Since The Start Of 2023, Can MetLife Stock Rebound?
- Trailing The S&P Index By 30% YTD, Can MetLife Stock Recoup Its Losses?
- Where Is MetLife Stock Headed?
| Return Period | MET | S&P 500 |
|---|---|---|
| 1D | 2.8% | 1.5% |
| 5D (Current Streak) | 5.4% | 0.3% |
| 1M (21D) | 5.6% | 1.6% |
| 3M (63D) | 5.7% | 10.7% |
| YTD 2025 | 1.7% | 10.0% |
| 2024 | 27.7% | 23.3% |
| 2023 | -5.5% | 24.2% |
| 2022 | 19.2% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has MET behaved after prior drops? See MET Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 58 S&P constituents with 3 days or more of consecutive gains and 8 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 20 | 3 |
| 4D | 24 | 5 |
| 5D | 12 | 0 |
| 6D | 2 | 0 |
| 7D or more | 0 | 0 |
| Total >=3 D | 58 | 8 |
Key Financials for MetLife (MET)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $66.4 Bil | $69.9 Bil |
| EBT | $2.2 Bil | $5.6 Bil |
| Net Income | $1.6 Bil | $4.4 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $18.3 Bil | $17.2 Bil |
| EBT | $1.4 Bil | $980.0 Mil |
| Net Income | $945.0 Mil | $729.0 Mil |
While MET stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.